par Katerin Grajales Il y a 7 années
285
Plus de détails
par Jenny Thomas
par Nadine Dunstone
par Paul Santos
par Carlos Arturo Valencia
Nevertheless, our study was not powered to detect differences in mortality. Further multi-center, randomized, controlled trials are needed to investigate the possible benefits of sedation with isoflurane in patients with ARDS.
The strategy was feasible, with theoretical advantages including bronchodilation, cardiovascular and lung-protective effects, good control of the level of sedation.